1. A systematic evidence map of the association between cannabis use and psychosis-related outcomes across the psychosis continuum: An umbrella review of systematic reviews and meta-analyses.
- Author
-
Groening, Johanna Manja, Denton, Emma, Parvaiz, Rimsha, Brunet, David Losada, Von Daniken, Aisha, Shi, Yiling, and Bhattacharyya, Sagnik
- Subjects
- *
PSYCHOSES , *CAUSAL inference , *PUBLIC opinion , *UMBRELLAS , *STATUS (Law) - Abstract
• Current systematic reviews and meta-analyses of observational studies that investigate the association between cannabis use and psychosis-related outcomes across the psychosis continuum show discrepant results and do not allow causal inferences. • Cannabis use was found to be associated with subclinical psychosis states (psychotic-like experiences) and traits (schizotypal personality) in the healthy population, as well as earlier onset and development of psychosis. • Cannabis use neither seems to be associated with the Clinical-high-risk state for psychosis nor with attenuated symptom severity and transition to psychosis in this population. An association in the psychosis population could only be confirmed between cannabis and relapse, not symptom severity. • More primary studies are needed to define the interplay between cannabis use and other environmental and genetic factors using large-scale genetic and epigenetic studies. While the legal status and public perception of cannabis are currently changing in many countries, one of the important considerations from a public health viewpoint is its potential association with adverse health outcomes such as the development of psychosis. We conducted an umbrella review of systematic reviews and meta-analyses using the AMSTAR-2 to assess the quality of included reviews. We further created an evidence map to visualize and facilitate the overview of the published evidence synthesis on the association between cannabis use and all psychosis-related outcomes and risk moderators in healthy, high-risk, and clinical populations. Overall, we found 32 systematic reviews and meta-analyses. Based on a synthesis of current evidence, cannabis use is associated with subclinical psychosis states (psychotic-like experiences) and traits (schizotypal personality) in the healthy population, as well as earlier onset and development of psychosis. An association with the clinical-high-risk state for psychosis, attenuated psychosis symptoms and transition to psychosis in this population could not be confirmed. An association between cannabis use and psychosis outcomes in patients with psychotic disorder could solely be confirmed regarding relapse. Whether causal effects underlie those associations has not sufficiently been addressed in the evidence synthesis to date. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF